Sponsored

  • Cervical Locking Screw

    Cervical Locking Screw is a spinal implant that is used for the treatment of various spinal conditions. These screws are used to fix other cervical implants in place. Siora Surgicals Pvt. Ltd., an Indian-FDA-approved orthopedic device company manufactures these screws using medical-grade titanium. They are available in diameter sizes of 4.0 mm and lengths ranging from 10 to 30 mm. Siora is also an experienced OEM/contract manufacturing service provider.

    https://www.siiora.com/product/cervical-locking-screw/

    Cervical Locking Screw Cervical Locking Screw is a spinal implant that is used for the treatment of various spinal conditions. These screws are used to fix other cervical implants in place. Siora Surgicals Pvt. Ltd., an Indian-FDA-approved orthopedic device company manufactures these screws using medical-grade titanium. They are available in diameter sizes of 4.0 mm and lengths ranging from 10 to 30 mm. Siora is also an experienced OEM/contract manufacturing service provider. https://www.siiora.com/product/cervical-locking-screw/
    0 Comments 0 Shares
  • Italian Femoral Arch - 120⁰ Aluminum
    India
    Other آخر
    Italian Femoral Arch - 120⁰ Aluminum is a part of an external ring fixator that is used for the treatment of various orthopedic deformities and injuries that cannot be managed with conventional surgical and non-surgical methods. Schanz screw is often used to stabilize this implant. This implant also finds the application to improve the range of motion of the knee.
    Siora Surgicals Pvt. Ltd. is an experienced orthopedic device manufacturer in India with over 3 decades in the industry. The company produces a CE-certified range of orthopedic implants including Italian Femoral Arch - 120⁰ Aluminum. Being an Indian-FDA-approved company, Siora is also proud to be counted among the best OEM/contract manufacturing service providers across the globe.

    https://www.siiora.org/product/italian-femoral-arch-120-degree/
    Italian Femoral Arch - 120⁰ Aluminum is a part of an external ring fixator that is used for the treatment of various orthopedic deformities and injuries that cannot be managed with conventional surgical and non-surgical methods. Schanz screw is often used to stabilize this implant. This implant also finds the application to improve the range of motion of the knee. Siora Surgicals Pvt. Ltd. is an experienced orthopedic device manufacturer in India with over 3 decades in the industry. The company produces a CE-certified range of orthopedic implants including Italian Femoral Arch - 120⁰ Aluminum. Being an Indian-FDA-approved company, Siora is also proud to be counted among the best OEM/contract manufacturing service providers across the globe. https://www.siiora.org/product/italian-femoral-arch-120-degree/
    Type
    New
    Price
    $25 (USD)
    Status
    In stock
    0 Comments 0 Shares
  • The antibody contract manufacturing market is projected to reach USD 17 billion by 2030

    With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html
    The antibody contract manufacturing market is projected to reach USD 17 billion by 2030 With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone For additional details, please visit https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html
    WWW.ROOTSANALYSIS.COM
    Antibody Contract Manufacturing | Industry Analysis | Market Size | 2030
    Market research report on antibody contract manufacturing market, with a focus on current landscape and future growth opportunities
    0 Comments 0 Shares
  • Italian Femoral Arch 90° - S.S
    India
    Other آخر
    Italian Femoral Arch 90° - S.S is intended to be used for the treatment of joint fractures that cannot be managed with conventional methods. Made of medical-grade stainless steel, this femoral arch is a part of the Ilizarov external fixator system. This implant is known for femoral lengthening and is stabilized using Schanz screws.
    Siora Surgicals Pvt. Ltd. is an experienced manufacturer of Italian Femoral Arch 90° - S.S and other orthopedic devices. Based in India, the company is known to have experience of over 30 years and is serving around 130 national and international distributors. Siora is also a trustworthy OEM/contract manufacturing service provider across the globe.

    https://www.siiora.org/product/italian-femoral-arch-90-degree/
    Italian Femoral Arch 90° - S.S is intended to be used for the treatment of joint fractures that cannot be managed with conventional methods. Made of medical-grade stainless steel, this femoral arch is a part of the Ilizarov external fixator system. This implant is known for femoral lengthening and is stabilized using Schanz screws. Siora Surgicals Pvt. Ltd. is an experienced manufacturer of Italian Femoral Arch 90° - S.S and other orthopedic devices. Based in India, the company is known to have experience of over 30 years and is serving around 130 national and international distributors. Siora is also a trustworthy OEM/contract manufacturing service provider across the globe. https://www.siiora.org/product/italian-femoral-arch-90-degree/
    Type
    New
    Price
    $27 (USD)
    Status
    In stock
    0 Comments 0 Shares
  • Advantages of Electronic Contract Manufacturing
    Contract manufacturing offers a variety of different benefits. The top 4 benefits that come with contract manufacturing include. Visit https://bit.ly/32pdnQW for more info.
    #electroniccontractmanufacturingservices
    Advantages of Electronic Contract Manufacturing Contract manufacturing offers a variety of different benefits. The top 4 benefits that come with contract manufacturing include. Visit https://bit.ly/32pdnQW for more info. #electroniccontractmanufacturingservices
    0 Comments 0 Shares
  • Foot Ring Short (Adult) - S.S
    India
    Other آخر
    Foot Ring Short (Adult) - S.S is a part of an external fixator system that is used for the surgical treatment of severe fractures, bone deformities, and limb length discrepancies. This implant is known to provide stability to injured/affected bone. Siora Surgicals Pvt. manufactures this ring using medical-grade stainless steel and titanium. The company is also known to provide a CE-certified range of other orthopedic devices that are also exported to other countries. You can also avail high-quality OEM/contract manufacturing services from Siora.

    https://www.siiora.com/product/foot-ring-short-adult-s-s/
    Foot Ring Short (Adult) - S.S is a part of an external fixator system that is used for the surgical treatment of severe fractures, bone deformities, and limb length discrepancies. This implant is known to provide stability to injured/affected bone. Siora Surgicals Pvt. manufactures this ring using medical-grade stainless steel and titanium. The company is also known to provide a CE-certified range of other orthopedic devices that are also exported to other countries. You can also avail high-quality OEM/contract manufacturing services from Siora. https://www.siiora.com/product/foot-ring-short-adult-s-s/
    Type
    New
    Price
    $23 (USD)
    Status
    In stock
    0 Comments 0 Shares
  • The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis

    Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Market (4th Edition), 2020-2030.”

    The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. The study features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:
     A detailed assessment of the current market landscape of drug developers engaged in the development of bispecific antibody therapeutics.
     A comprehensive analysis of novel technology platforms that are either currently available or being developed for the generation of bispecific antibody therapeutics.
     Detailed profiles of marketed and clinical stage (phase II and phase III) bispecific antibody therapeutics.
     Key takeaways from the bispecific antibody therapeutics pipeline.
     An analysis of the initiatives of big biopharma players engaged in this domain.
     An analysis of recent partnerships and collaboration agreements inked in bispecific antibody therapeutics domain.
     A review on the key steps involved and challenges associated with the manufacturing of bispecific antibodies.
     A clinical trial analysis of ongoing and planned studies related to bispecific antibody therapeutics.
     A review of the key promotional strategies that have been adopted by the developers of the marketed bispecific antibodies.
     A discussion on important, industry-specific trends, key market drivers and challenges, under a SWOT framework.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
     Target Disease Indication
     Autoimmune Disorders
     Eye Disorders
     Genetic Disorders
     Hematological Malignancies
     Infectious Diseases
     Inflammatory Disorders
     Skin Disorders
     Mechanism of Action
     Cytokines Retargeting / Neutralization
     Dual Ligands Blocking
     T-cell Retargeting / Activation
     Others
     Target Antigens
     CD3 x CD19
     CD30 x CD16A
     Factor IXa x Factor X
     IL-1α x IL-1β
     IL-13 x IL-4
     IL-17A x Albumin
     IL-17A x IL-17F
     Psl x PcrV
     TNF-α x HAS
     VEGF-A x ANG2
     Others
     Antibody Format
     Asymmetric
     Fragments
     Symmetric
     Others
     Key Geographical Region
     North America
     Europe
     Asia-Pacific

    Transcripts of interviews held with the following senior level representatives of stakeholder companies:
     Martin Steiner (Chief Executive Officer, Synimmune)
     Ludger Große-Hovest (Chief Scientific Officer, Synimmune)
     Jane Dancer (Chief Business Officer, F-Star)
     Siobhan Pomeroy (Senior Director, Business Development, Cytom X)
     Yinjue Wang (Associate Director, Process Development, Innovent Biologics)

    Key companies covered in the report
     Amgen
     Ablynx
     AbbVie
     Affibody
     Affimed
     Alphamab
     AstraZeneca
     Avillion
     Chugai Pharmaceuticals
     Eddingpharm
     GSK
     Merck
     Merus
     Roche
     Regeneron Pharmaceuticals
     Taisho Pharmaceuticals
     Zymeworks

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html

    Other Recent Offerings
    1. Global Preventive Vaccines Market, 2020-2030
    2. Endocannabinoid System Targeted Therapeutics Market, 2019-2030
    3. Antibody Contract Manufacturing Market, 2020-2030

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

    Contact Information
    Roots Analysis Private Limited
    Ben Johnson
    +1 (415) 800 3415
    [email protected]
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    Medium - https://medium.com/@RootsAnalysis
    Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
    Quora - https://rootsanalysisinsights.quora.com/
    The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Market (4th Edition), 2020-2030.” The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. The study features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:  A detailed assessment of the current market landscape of drug developers engaged in the development of bispecific antibody therapeutics.  A comprehensive analysis of novel technology platforms that are either currently available or being developed for the generation of bispecific antibody therapeutics.  Detailed profiles of marketed and clinical stage (phase II and phase III) bispecific antibody therapeutics.  Key takeaways from the bispecific antibody therapeutics pipeline.  An analysis of the initiatives of big biopharma players engaged in this domain.  An analysis of recent partnerships and collaboration agreements inked in bispecific antibody therapeutics domain.  A review on the key steps involved and challenges associated with the manufacturing of bispecific antibodies.  A clinical trial analysis of ongoing and planned studies related to bispecific antibody therapeutics.  A review of the key promotional strategies that have been adopted by the developers of the marketed bispecific antibodies.  A discussion on important, industry-specific trends, key market drivers and challenges, under a SWOT framework.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Target Disease Indication  Autoimmune Disorders  Eye Disorders  Genetic Disorders  Hematological Malignancies  Infectious Diseases  Inflammatory Disorders  Skin Disorders  Mechanism of Action  Cytokines Retargeting / Neutralization  Dual Ligands Blocking  T-cell Retargeting / Activation  Others  Target Antigens  CD3 x CD19  CD30 x CD16A  Factor IXa x Factor X  IL-1α x IL-1β  IL-13 x IL-4  IL-17A x Albumin  IL-17A x IL-17F  Psl x PcrV  TNF-α x HAS  VEGF-A x ANG2  Others  Antibody Format  Asymmetric  Fragments  Symmetric  Others  Key Geographical Region  North America  Europe  Asia-Pacific Transcripts of interviews held with the following senior level representatives of stakeholder companies:  Martin Steiner (Chief Executive Officer, Synimmune)  Ludger Große-Hovest (Chief Scientific Officer, Synimmune)  Jane Dancer (Chief Business Officer, F-Star)  Siobhan Pomeroy (Senior Director, Business Development, Cytom X)  Yinjue Wang (Associate Director, Process Development, Innovent Biologics) Key companies covered in the report  Amgen  Ablynx  AbbVie  Affibody  Affimed  Alphamab  AstraZeneca  Avillion  Chugai Pharmaceuticals  Eddingpharm  GSK  Merck  Merus  Roche  Regeneron Pharmaceuticals  Taisho Pharmaceuticals  Zymeworks For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html Other Recent Offerings 1. Global Preventive Vaccines Market, 2020-2030 2. Endocannabinoid System Targeted Therapeutics Market, 2019-2030 3. Antibody Contract Manufacturing Market, 2020-2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected] Contact Information Roots Analysis Private Limited Ben Johnson +1 (415) 800 3415 [email protected] Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/
    WWW.ROOTSANALYSIS.COM
    Bispecific Antibody Therapeutics Market (4th Edition) | Market Size | Industry Analysis | 2030
    Market research report on bispecific antibody therapeutics; the study includes details on current market landscape and future growth opportunities
    0 Comments 0 Shares
  • Contract manufacturing of tea | Private Labelling - Sugandh tea

    Sugandh tea - We have developed expertise in the field of contract manufacturing of tea. We are the leading manufacturer of Darjeeling and Assam healthy tea in India.

    https://sugandhtea.com/
    Contract manufacturing of tea | Private Labelling - Sugandh tea Sugandh tea - We have developed expertise in the field of contract manufacturing of tea. We are the leading manufacturer of Darjeeling and Assam healthy tea in India. https://sugandhtea.com/
    Home
    0 Comments 0 Shares
  • The “Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030” report features an extensive study on the contract service providers within the biopharmaceutical industry

    An analysis on the recent trends within biopharmaceutical contract manufacturing industry, highlighting various facility and capability expansions. In addition, it provides information on the technology advancements related to biomanufacturing.

    To order this 750+ page report, please visit this - https://rootsanalysis.com/reports/view_document/biopharma-contract-manufacturing-market-3rd-edition-2019-2030/250.html
    The “Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030” report features an extensive study on the contract service providers within the biopharmaceutical industry An analysis on the recent trends within biopharmaceutical contract manufacturing industry, highlighting various facility and capability expansions. In addition, it provides information on the technology advancements related to biomanufacturing. To order this 750+ page report, please visit this - https://rootsanalysis.com/reports/view_document/biopharma-contract-manufacturing-market-3rd-edition-2019-2030/250.html
    0 Comments 0 Shares
  • Contract manufacturing of tea | Private Labelling - Sugandh tea

    Sugandh tea - We have developed expertise in the field of contract manufacturing of tea. We are the leading manufacturer of Darjeeling and Assam healthy tea in India.

    https://sugandhtea.com/
    Contract manufacturing of tea | Private Labelling - Sugandh tea Sugandh tea - We have developed expertise in the field of contract manufacturing of tea. We are the leading manufacturer of Darjeeling and Assam healthy tea in India. https://sugandhtea.com/
    0 Comments 0 Shares
More Results
Sponsored
Sponsored
Sponsored
Sponsored
Al-Quds University